Matches in SemOpenAlex for { <https://semopenalex.org/work/W2937055384> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2937055384 endingPage "117" @default.
- W2937055384 startingPage "111" @default.
- W2937055384 abstract "Antiretroviral therapy as a life-long treatment has to meet the criteria of maximum efficiency while maintaining the highest possible level of safety and tolerance. Tenofovir disoproxil fumarate (TDF) is an antiretroviral drug with an excellent effect of virological suppression. However, some patients can over time develop clinically significant nephrotoxicity or bone loss. Tenofovir alafenamide fumarate (TAF) is a novel prodrug of tenofovir (TFV) that is more stable in human plasma and more efficiently penetrates into target cells than TFV. Tenofovir converted from TAF reaches plasma concentration which is 90% lower than that of TFV converted from TDF. Conversely, the active metabolite converted from TAF reaches a higher intracellular level in target cells than TFV from TDF. This allows a substantial reduction of its oral dose, decreasing the risk for renal and bone toxicity. It is even possible to reduce the dose of TAF in case it is administered concurrently with cobicistat further improving its absorption and optimizing its pharmacokinetic profile. Pharmacokinetic properties are another factor substantially influencing its safety profile. TAF is not a substrate for renal organic anion transporters and thus shows no cytotoxicity related to their expression. Based on clinical trials, a fixed-dose combination tablet (single-tablet regimen) containing elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate was approved by the FDA in November 2015. This regimen showed higher efficacy, better safety profile and tolerance than TDF-based regiments. Recently, it has been approved in European Union countries." @default.
- W2937055384 created "2019-04-25" @default.
- W2937055384 creator A5015332236 @default.
- W2937055384 creator A5041339491 @default.
- W2937055384 creator A5048519730 @default.
- W2937055384 date "2016-09-01" @default.
- W2937055384 modified "2023-09-26" @default.
- W2937055384 title "[Tenofovir alafenamide fumarate - a new generation of tenofovir]." @default.
- W2937055384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27907972" @default.
- W2937055384 hasPublicationYear "2016" @default.
- W2937055384 type Work @default.
- W2937055384 sameAs 2937055384 @default.
- W2937055384 citedByCount "1" @default.
- W2937055384 countsByYear W29370553842020 @default.
- W2937055384 crossrefType "journal-article" @default.
- W2937055384 hasAuthorship W2937055384A5015332236 @default.
- W2937055384 hasAuthorship W2937055384A5041339491 @default.
- W2937055384 hasAuthorship W2937055384A5048519730 @default.
- W2937055384 hasConcept C108215921 @default.
- W2937055384 hasConcept C112705442 @default.
- W2937055384 hasConcept C126322002 @default.
- W2937055384 hasConcept C142462285 @default.
- W2937055384 hasConcept C159047783 @default.
- W2937055384 hasConcept C2777068322 @default.
- W2937055384 hasConcept C2779778239 @default.
- W2937055384 hasConcept C2780524789 @default.
- W2937055384 hasConcept C2781413609 @default.
- W2937055384 hasConcept C2911190787 @default.
- W2937055384 hasConcept C2993143319 @default.
- W2937055384 hasConcept C3013748606 @default.
- W2937055384 hasConcept C71924100 @default.
- W2937055384 hasConcept C98274493 @default.
- W2937055384 hasConceptScore W2937055384C108215921 @default.
- W2937055384 hasConceptScore W2937055384C112705442 @default.
- W2937055384 hasConceptScore W2937055384C126322002 @default.
- W2937055384 hasConceptScore W2937055384C142462285 @default.
- W2937055384 hasConceptScore W2937055384C159047783 @default.
- W2937055384 hasConceptScore W2937055384C2777068322 @default.
- W2937055384 hasConceptScore W2937055384C2779778239 @default.
- W2937055384 hasConceptScore W2937055384C2780524789 @default.
- W2937055384 hasConceptScore W2937055384C2781413609 @default.
- W2937055384 hasConceptScore W2937055384C2911190787 @default.
- W2937055384 hasConceptScore W2937055384C2993143319 @default.
- W2937055384 hasConceptScore W2937055384C3013748606 @default.
- W2937055384 hasConceptScore W2937055384C71924100 @default.
- W2937055384 hasConceptScore W2937055384C98274493 @default.
- W2937055384 hasIssue "3" @default.
- W2937055384 hasLocation W29370553841 @default.
- W2937055384 hasOpenAccess W2937055384 @default.
- W2937055384 hasPrimaryLocation W29370553841 @default.
- W2937055384 hasRelatedWork W2121444503 @default.
- W2937055384 hasRelatedWork W2121858968 @default.
- W2937055384 hasRelatedWork W2183163677 @default.
- W2937055384 hasRelatedWork W2264012645 @default.
- W2937055384 hasRelatedWork W2304700272 @default.
- W2937055384 hasRelatedWork W2404855614 @default.
- W2937055384 hasRelatedWork W2407090191 @default.
- W2937055384 hasRelatedWork W2436632045 @default.
- W2937055384 hasRelatedWork W2530847808 @default.
- W2937055384 hasRelatedWork W2560008422 @default.
- W2937055384 hasRelatedWork W2567879141 @default.
- W2937055384 hasRelatedWork W2770502589 @default.
- W2937055384 hasRelatedWork W2785052952 @default.
- W2937055384 hasRelatedWork W2796622273 @default.
- W2937055384 hasRelatedWork W2989249725 @default.
- W2937055384 hasRelatedWork W2990373619 @default.
- W2937055384 hasRelatedWork W3080845140 @default.
- W2937055384 hasRelatedWork W3130912161 @default.
- W2937055384 hasRelatedWork W3153805097 @default.
- W2937055384 hasRelatedWork W2584289553 @default.
- W2937055384 hasVolume "22" @default.
- W2937055384 isParatext "false" @default.
- W2937055384 isRetracted "false" @default.
- W2937055384 magId "2937055384" @default.
- W2937055384 workType "article" @default.